Navigation Links
Going bananas for sustainable research -- scientists create fuel from African crop waste
Date:4/6/2009

Bananas are a staple crop of Rwanda. The fruit is eaten raw, fried and baked it even produces banana beer and wine. Around 2 million tons are grown each year but the fruit is only a small percentage of what the plant produces. The rest skins, leaves and stems is left to rot as waste.

Now scientists at The University of Nottingham are looking at ways to use that waste to produce fuel, developing simple methods of producing banana briquettes that could be burnt for cooking and heating. PhD student Joel Chaney in the Faculty of Engineering has developed a method of producing the briquettes using minimal tools and technology, which could be used in communities all over Africa.

First, the banana skins and leaves are mashed to a pulp in a hand-operated domestic meat mincer. This pulp is mixed with sawdust to create a mouldable material in Rwanda it would be mixed with sun dried banana stems, ensuring the whole plant is used.

Then, the pulp mix is compressed into briquette shapes and baked in an oven at 105 degrees. Again, in Africa the fuel would be left for a few days to dry in the sun.

Once dried, the briquettes form an ideal fuel, burning with a consistent steady heat suitable for cooking. Joel has tested this himself by cooking fried banana fritters, which is similar to "red-red" a popular Ghanaian dish.

"A big problem in the developing world is firewood," said Joel. "Huge areas of land are deforested every year, which leads to the land being eroded. People need fuel to cook and stay warm but they can't afford the more expensive types, like gas.

"As well as the environmental damage this causes, it also takes a lot of time. Women can spend four or five hours a day just collecting firewood. If an alternative fuel could be found they could spend this time doing other things even generating an income.

"Using waste to create fuel is key to sustainable development, and this method could be easily tra
'/>"/>

Contact: Dr. Mike Clifford
mike.clifford@nottingham.ac.uk
44-115-846-6134
University of Nottingham
Source:Eurekalert

Page: 1 2

Related biology news :

1. Lobster traps going high tech
2. New infant feeding and obesity research adds insight to ongoing issue
3. How mirror neurons allow us to learn and socialize by going through the motions in the head
4. 70 years old and going strong with Down syndrome and no dementia
5. National Zoo scimitar-horned oryx going into the wild
6. Going live with click chemistry
7. Georgia goes bananas
8. Blue bananas
9. Biofuels can provide viable, sustainable solution to reducing petroleum dependence
10. Biggest ever public investment in bioenergy to help provide clean, green and sustainable fuels
11. New publishing partnership for Energy for Sustainable Development
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3